Skip to content

Martine A Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS, sold UTHR on Aug 25, 2026

Data as of Oct 16

▼ SELL$1M2,029 shares at $516.12Martine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp
Watch UTHR
Traded
Aug 25, 2026
Disclosed
Aug 26, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Martine A Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS, sold UTHR on Aug 25, 2026TRADEDDISCLOSED
UTHRSimilar stocks (XLV — its sector index fund), rebased to UTHR's price on the disclosure day
UTHR since disclosure
+3.2%
after the sale
Similar stocks (XLV) since disclosure
+1.8%
XLV — its sector index fund

Change in closing price from Aug 26, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$1.2Mdisclosed Aug 26 · filed 1 day after the trade
  2. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$41.6Kdisclosed Aug 26 · filed 1 day after the trade
  3. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$1Mdisclosed Aug 26 · filed 1 day after the trade
  4. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$347Kdisclosed Aug 26 · filed 1 day after the trade
  5. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$1.2Mdisclosed Aug 26 · filed 1 day after the trade

See every trade on UTHR →